AOCI at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's AOCI?
- Charles River Laboratories (CRL) reported AOCI of -$191.04M in Q1 2026.
- How has Charles River Laboratories's AOCI changed year-over-year?
- Charles River Laboratories's AOCI increased by 28.0% year-over-year, from -$265.25M to -$191.04M.
- What is the long-term trend for Charles River Laboratories's AOCI?
- Over 5 years (2020 to 2025), Charles River Laboratories's AOCI has grown at a 4.3% compound annual growth rate (CAGR), from -$138.87M to -$171.78M.
- What does AOCI mean?
- Cumulative gains or losses from items like currency changes and investments that haven't hit the income statement yet.
- How do you interpret AOCI?
- High volatility in AOCI can obscure the underlying operational performance of the company.
- How does AOCI compare across companies?
- Varies significantly based on the company's international exposure and investment portfolio size.